Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 12-Sep-23 6:20 PM View:  | Perkins Adelene Q Director | Infinity Pharmaceuticals, I... (INFI) | 12-Sep-23 | Planned Option Sale | 410,196 | $0.07 | $28,713.70 | (26%) 1.6M to 1.19M | |
| 12-Sep-23 6:20 PM View: | Perkins Adelene Q Director | Infinity Pharmaceuticals, I... (INFI) | 09-Sep-23 | Option Exercise | 768,133 | -- | -- | 92% 833.8K to 1.6M | |
| 04-Aug-22 6:26 PM View: | Peluso Stephane Chief Scientific Officer | Infinity Pharmaceuticals, I... (INFI) | 02-Aug-22 | Option Sale | 14,994 | $0.66 | $9,932.03 | 68% 22.06K to 37.05K | |
| 16-Jun-22 8:32 PM View: | Schwartz Brian Director | Infinity Pharmaceuticals, I... (INFI) | 16-Jun-22 | Grant | 30,919 | $0.68 | $20,994.00 | 100% 0 to 30.92K | |
| 16-Jun-22 9:29 PM View: | Evnin Anthony B Director | Infinity Pharmaceuticals, I... (INFI) | 16-Jun-22 | Grant | 46,378 | $0.68 | $31,490.70 | 27% 169.03K to 215.4K | |
| 11-Jun-21 4:15 PM View: | Evnin Anthony B Director | Infinity Pharmaceuticals, I... (INFI) | 10-Jun-21 | Grant | 3,061 | $3.43 | $10,499.20 | 2% 165.96K to 169.03K | 0% |
| 11-Jun-21 4:17 PM View: | Beier David W Director | Infinity Pharmaceuticals, I... (INFI) | 10-Jun-21 | Grant | 3,061 | $3.43 | $10,499.20 | 54% 5.71K to 8.78K | 0% |
| 18-May-21 4:32 PM View: | Selby Norman C Director | Infinity Pharmaceuticals, I... (INFI) | 14-May-21 | Option Exercise | 5,000 | $0.92 | $4,600.00 | 50% 10.0K to 15.0K | |
| 16-Feb-21 10:00 PM View: | Bvf Partners L P/il 10% Owner | Infinity Pharmaceuticals, I... (INFI) | 11-Feb-21 | Market Sale | 2,260,080 | $5.37 | $12,133,500.00 | (21%) 10.52M to 8.26M | 25% |
| 26-Jan-21 5:27 PM View: | Bvf Partners L P/il 10% Owner | Infinity Pharmaceuticals, I... (INFI) | 22-Jan-21 | Market Sale | 5,848,520 | $4.14 | $24,205,900.00 | (36%) 16.37M to 10.52M | 5% |
| 18-Jun-20 8:30 AM View: | Evnin Anthony B Director | Infinity Pharmaceuticals, I... (INFI) | 17-Jun-20 | Grant | 22,826 | -- | -- | 16% 143.14K to 165.96K | |
| 13-Jan-20 5:01 PM View: | Kutok Jeffery Chief Scientific Officer | Infinity Pharmaceuticals, I... (INFI) | 10-Jan-20 | Grant | 64,219 | -- | -- | 269% 23.9K to 88.12K | |
| 13-Jan-20 5:00 PM View: | Perkins Adelene Q Chief Executive Officer | Infinity Pharmaceuticals, I... (INFI) | 10-Jan-20 | Grant | 155,134 | -- | -- | 24% 654.5K to 809.64K | |
| 13-Jan-20 5:01 PM View: | Tasker Seth A Chief Business Officer | Infinity Pharmaceuticals, I... (INFI) | 10-Jan-20 | Grant | 53,538 | -- | -- | 90% 59.74K to 113.28K | |
| 13-Jan-20 5:01 PM View: | Bloch Lawrence E President | Infinity Pharmaceuticals, I... (INFI) | 10-Jan-20 | Grant | 83,157 | -- | -- | 12% 675.15K to 758.31K | |
| 14-Jun-19 4:05 PM View: | Berkowitz Jeffrey Director | Infinity Pharmaceuticals, I... (INFI) | 13-Jun-19 | Grant | 26,250 | $1.60 | $42,000.00 | 45% 58.99K to 85.24K | 31% |
| 14-Jun-19 4:06 PM View: | Evnin Anthony B Director | Infinity Pharmaceuticals, I... (INFI) | 13-Jun-19 | Grant | 13,125 | $1.60 | $21,000.00 | 10% 130.01K to 143.14K | 31% |
| 17-Dec-18 7:40 PM View: | Bvf Partners L P/il 10% Owner | Infinity Pharmaceuticals, I... (INFI) | 13-Dec-18 | Market Purchase | 175,000 | $1.20 | $209,912.00 | 1% 16.2M to 16.37M | 76% |
| 30-Nov-18 6:28 PM View: | Bvf Partners L P/il 10% Owner | Infinity Pharmaceuticals, I... (INFI) | 28-Nov-18 | Market Purchase | 100,000 | $1.30 | $130,000.00 | < 1% 16.1M to 16.2M | 62% |
| 21-Nov-18 5:57 PM View: | Bvf Partners L P/il 10% Owner | Infinity Pharmaceuticals, I... (INFI) | 21-Nov-18 | Market Purchase | 4,700 | $1.35 | $6,345.00 | < 1% 16.09M to 16.1M | 56% |
| 21-Nov-18 5:57 PM View: | Bvf Partners L P/il 10% Owner | Infinity Pharmaceuticals, I... (INFI) | 19-Nov-18 | Market Purchase | 1,465,130 | $1.37 | $2,005,080.00 | 10% 14.63M to 16.09M | 54% |
| 15-Nov-18 8:07 PM View: | Bvf Partners L P/il 10% Owner | Infinity Pharmaceuticals, I... (INFI) | 15-Nov-18 | Market Purchase | 91,474 | $1.35 | $123,490.00 | < 1% 14.54M to 14.63M | 56% |
| 15-Nov-18 8:07 PM View: | Bvf Partners L P/il 10% Owner | Infinity Pharmaceuticals, I... (INFI) | 14-Nov-18 | Market Purchase | 210,250 | $1.34 | $281,735.00 | 1% 14.33M to 14.54M | 57% |
| 15-Nov-18 8:07 PM View: | Bvf Partners L P/il 10% Owner | Infinity Pharmaceuticals, I... (INFI) | 13-Nov-18 | Market Purchase | 604,208 | $1.35 | $815,681.00 | 4% 13.72M to 14.33M | 56% |
| 02-Oct-18 4:30 PM View: | Perkins Adelene Q Chief Executive Officer Director | Infinity Pharmaceuticals, I... (INFI) | 01-Oct-18 | Market Sale (Planned) | 5,000 | $2.82 | $14,100.00 | (< 1%) 631.01K to 626.01K | 25% |
| 17-Aug-18 4:05 PM View: | Kutok Jeffery Chief Scientific Officer | Infinity Pharmaceuticals, I... (INFI) | 16-Aug-18 | Market Sale (Planned) | 6,133 | $2.00 | $12,266.00 | (39%) 15.68K to 9.54K | (6%) |
| 17-Aug-18 4:05 PM View: | Kutok Jeffery Chief Scientific Officer | Infinity Pharmaceuticals, I... (INFI) | 15-Aug-18 | Market Sale (Planned) | 8,180 | $2.01 | $16,420.50 | (34%) 23.86K to 15.68K | (5%) |
| 25-Jun-18 5:00 PM View: | Kutok Jeffery Chief Scientific Officer | Infinity Pharmaceuticals, I... (INFI) | 22-Jun-18 | Market Sale (Planned) | 14,313 | $2.00 | $28,694.70 | (39%) 36.64K to 22.32K | (6%) |
| 21-Jun-18 6:57 PM View: | Bvf Partners L P/il 10% Owner | Infinity Pharmaceuticals, I... (INFI) | 21-Jun-18 | Market Purchase | 425,531 | $1.65 | $702,126.00 | 3% 13.3M to 13.72M | 29% |
| 21-Jun-18 6:57 PM View: | Bvf Partners L P/il 10% Owner | Infinity Pharmaceuticals, I... (INFI) | 19-Jun-18 | Market Purchase | 3,516,560 | $1.65 | $5,802,320.00 | 36% 9.78M to 13.3M | 29% |
| 14-Jun-18 8:34 AM View: | Smith Ian F Director | Infinity Pharmaceuticals, I... (INFI) | 12-Jun-18 | Grant | 22,857 | $1.75 | $39,999.80 | 99% 22.99K to 45.84K | 21% |
| 14-Jun-18 8:30 AM View: | Beier David W Director | Infinity Pharmaceuticals, I... (INFI) | 12-Jun-18 | Grant | 5,714 | $1.75 | $9,999.50 | 100% 0 to 5.71K | 21% |
| 14-Jun-18 8:33 AM View: | Evnin Anthony B Director | Infinity Pharmaceuticals, I... (INFI) | 12-Jun-18 | Grant | 11,428 | $1.75 | $19,999.00 | 10% 118.58K to 130.01K | 21% |
| 14-Jun-18 8:35 AM View: | Berkowitz Jeffrey Director | Infinity Pharmaceuticals, I... (INFI) | 12-Jun-18 | Grant | 22,857 | $1.75 | $39,999.80 | 63% 36.13K to 58.99K | 21% |
| 11-Apr-18 6:01 PM View: | Bvf Partners L P/il 10% Owner | Infinity Pharmaceuticals, I... (INFI) | 10-Apr-18 | Market Purchase | 1,010,000 | $2.00 | $2,020,000.00 | 12% 8.77M to 9.78M | 6% |
| 11-Apr-18 6:01 PM View: | Bvf Partners L P/il 10% Owner | Infinity Pharmaceuticals, I... (INFI) | 09-Apr-18 | Market Purchase | 500,000 | $1.90 | $950,000.00 | 6% 8.27M to 8.77M | 12% |
| 07-Mar-18 4:22 PM View: | Perkins Adelene Q Chief Executive Officer Director | Infinity Pharmaceuticals, I... (INFI) | 05-Mar-18 | Market Sale (Planned) | 5,000 | $2.78 | $13,890.00 | (< 1%) 624.64K to 619.64K | 24% |
| 04-Jan-18 4:05 PM View: | Bloch Lawrence E President | Infinity Pharmaceuticals, I... (INFI) | 02-Jan-18 | Grant | 37,881 | -- | -- | 6% 597.21K to 635.09K | |
| 04-Jan-18 4:07 PM View: | Tasker Seth A General Counsel | Infinity Pharmaceuticals, I... (INFI) | 02-Jan-18 | Grant | 22,351 | -- | -- | 87% 25.69K to 48.04K | |
| 04-Jan-18 4:06 PM View: | Perkins Adelene Q Chief Executive Officer Director | Infinity Pharmaceuticals, I... (INFI) | 02-Jan-18 | Grant | 69,924 | -- | -- | 13% 554.72K to 624.64K | |
| 04-Jan-18 4:05 PM View: | Kutok Jeffery Chief Scientific Officer | Infinity Pharmaceuticals, I... (INFI) | 02-Jan-18 | Grant | 28,626 | -- | -- | 448% 6.39K to 35.02K | |
| 07-Dec-17 9:11 AM View: | Bloch Lawrence E President | Infinity Pharmaceuticals, I... (INFI) | 06-Dec-17 | Market Purchase | 500,000 | $1.81 | $905,000.00 | 556% 89.9K to 589.9K | 18% |
| 05-Oct-17 8:07 PM View: | Bvf Partners L P/il 10% Owner | Infinity Pharmaceuticals, I... (INFI) | 04-Oct-17 | Market Purchase | 653,449 | $1.28 | $839,029.00 | 9% 7.62M to 8.27M | 66% |
| 05-Oct-17 8:07 PM View: | Bvf Partners L P/il 10% Owner | Infinity Pharmaceuticals, I... (INFI) | 03-Oct-17 | Market Purchase | 946,597 | $1.24 | $1,169,050.00 | 14% 6.67M to 7.62M | 73% |
| 24-Jul-17 5:41 PM View: | Tasker Seth A General Counsel | Infinity Pharmaceuticals, I... (INFI) | 21-Jul-17 | Grant | 8,916 | -- | -- | 57% 15.67K to 24.59K | |
| 24-Jul-17 5:48 PM View: | Perkins Adelene Q Chief Executive Officer Director | Infinity Pharmaceuticals, I... (INFI) | 21-Jul-17 | Grant | 85,800 | -- | -- | 19% 461.61K to 547.41K | |
| 24-Jul-17 5:41 PM View: | Bloch Lawrence E President | Infinity Pharmaceuticals, I... (INFI) | 21-Jul-17 | Grant | 39,039 | -- | -- | 78% 49.96K to 89.0K | |
| 26-May-17 8:26 AM View: | Evnin Anthony B Director | Infinity Pharmaceuticals, I... (INFI) | 25-May-17 | Grant | 11,494 | $1.74 | $19,999.60 | 11% 107.09K to 118.58K | 23% |
| 26-May-17 8:28 AM View: | Berkowitz Jeffrey Director | Infinity Pharmaceuticals, I... (INFI) | 25-May-17 | Grant | 5,747 | $1.74 | $9,999.78 | 19% 30.38K to 36.13K | 23% |
| 26-May-17 8:23 AM View: | Smith Ian F Director | Infinity Pharmaceuticals, I... (INFI) | 25-May-17 | Grant | 22,988 | $1.74 | $39,999.10 | 100% 0 to 22.99K | 23% |
